Highlands Oncology Group - Duplicate 2

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company2 trials

Running trials

• Active, not recruiting

  A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

  NCT02057133· Phase 1· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

  NCT01594723· Phase 2· Eli Lilly and Company· Source